Technology areas: Biotechnology & Pharmaceuticals • Networking & Security
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Stellaromics, Inc. has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are handled by 2 distinct examiners across the distinct art units. This small portfolio shows a concentration of work with a very limited number of officials. The fact that the 3 pending actions are split between only the 2 distinct examiners suggests a higher degree of examiner-specific interaction than is seen in more dispersed portfolios.
The busiest examiner is SISSON, BRADLEY L, who is responsible for 2 pending office actions. This means that SISSON, BRADLEY L is overseeing the majority of the company's 3 pending actions. With only the distinct art units involved, the company's biotechnological filings are currently focused within a very narrow set of examination groups. Practitioners should prioritize understanding the specific preferences and past rulings of SISSON, BRADLEY L, as this individual has a significant influence on the overall portfolio. The concentration in the identified art units also allows for a more focused analysis of group-level trends.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SISSON, BRADLEY L | 2 | 19.7% | +20.5% |
| CARTER, RICHARD BRUCE | 1 | 65.2% | +19.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19236732 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | 40d |
| 19236720 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19236732 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | 40d |
| 19344306 | METHODS AND SYSTEMS FOR VOLUMETRIC IMAGING | CARTER, RICHARD BRUCE | — |
| 19236720 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | — |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 2485 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19344306 | METHODS AND SYSTEMS FOR VOLUMETRIC IMAGING | CARTER, RICHARD BRUCE | 2485 | DP | Non-Final OA | — | Pending | Sep 29, 2025 |
| 19236720 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | 1682 | §103 | Final Rejection | — | Pending | Jun 12, 2025 |
| 19236732 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | SISSON, BRADLEY L | 1682 | §103§112Other | Final Rejection | 40d | Pending | Jun 12, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial